Oral Oncology
Volume 46, Issue 9 , Pages e47-e53, September 2010

Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1α and the clinicopathological features of oral squamous cell carcinoma

  • Tzong-Ming Shieh

      Affiliations

    • Department of Dental Hygiene, School of Health Care, China Medical University, Taichung, Taiwan
  • ,
  • Kuo-Wei Chang

      Affiliations

    • Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei, Taiwan
    • Department of Dentistry, Taipei Veterans General Hospital, Taipei, Taiwan
  • ,
  • Hsi-Feng Tu

      Affiliations

    • Department of Dentistry, National Yang-Ming University Hospital, Yilan, Taiwan
  • ,
  • Yin-Hua Shih

      Affiliations

    • Department of Dental Hygiene, School of Health Care, China Medical University, Taichung, Taiwan
  • ,
  • Shun-Yao Ko

      Affiliations

    • Graduate Institute of Medical Science, Chang Jung Christian University, Tainan, Taiwan
  • ,
  • Yuan-Chien Chen

      Affiliations

    • Oral and Maxillofacial Surgery, China Medical University Hospital, Taichung, Taiwan
    • Department of Dentistry, College of Medicine, China Medical University, Taichung, Taiwan
  • ,
  • Chung-Ji Liu

      Affiliations

    • Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei, Taiwan
    • Oral and Maxillofacial Surgery, Taipei Mackay Memorial Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author at: Oral and Maxillofacial Surgery, Taipei Mackay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Zhongshan Dist., Taipei City 10449, Taiwan. Fax: +886 2 2543 3642.

Received 9 January 2010; received in revised form 6 April 2010; accepted 19 April 2010. published online 26 July 2010.

Summary 

Oral squamous cell carcinoma (OSCC) is a common malignancy. The incidence of OSCC is particularly high in some Asian countries because of the popularity of the habit of chewing areca. Hypoxia-inducible factor-1α (HIF-1α) is up-regulated in the hypoxic microenvironment to enhance tumor survival. Five polymorphisms have been identified in exon 12 of HIF-1α including the C1772T polymorphism causing P582S, and the G1790A polymorphism causing A588T of the HIF-1α protein. This study investigated the relationship between these functional polymorphisms and the risk of progression of OSCC. PCR and direct sequencing were utilized to compare the genotypic polymorphism and allelic frequency of HIF-1α in 96 normal controls and 305 OSCC patients. No statistically significant difference in C1772T and G1790A genotypes and allelic frequency between control and OSCC patients was found. However, multivariate analysis indicated that the A carrier of HIF-1α G1790A in OSCC patients was significantly higher in larger tumors than in the contrasting group with an adjusted odds ratio of 2.92. The T carrier of HIF-1α C1772T in buccal cancer patients was significantly higher in the non-areca-chewing group with an adjusted odds ratio of 0.111. The buccal cancer patients with C1772T or G1790A had lower recurrence frequency with an odds ratio of 0.266. These findings may suggest a correlation between the HIF-1α C1772T and G1790A polymorphisms and the growth of OSCC, and the decrease of OSCC recurrence frequency.

Keywords: Areca chewing, Hypoxia-inducible factor-1α (HIF-1α), Oral squamous cell carcinoma (OSCC), Single nucleotide polymorphism, Tumor size

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(10)00193-4

doi:10.1016/j.oraloncology.2010.04.009

Oral Oncology
Volume 46, Issue 9 , Pages e47-e53, September 2010